Target intelligence / Profile preview

Human immunodeficiency virus type 1 Gag, Pol, Nef, and Env proteins (HIV-1 Gag, Pol, Nef, and Env)

Target
HIV-1 Gag, Pol, Nef, and Env
Molecular classification
Other (Viral structural protein), Enzyme (Pol), Other (Accessory/regulatory protein - Nef), Other (Viral envelope glycoprotein - Env)
01

Overview

The **HIV-1 Gag, Pol, Nef, and Env proteins** are essential products of the HIV-1 genome that play fundamental roles in the viral life cycle. **Gag** (group-specific antigen) is a structural polyprotein required for virion assembly, genome packaging, and release. **Pol** provides enzymatic activities (reverse transcriptase, integrase, protease) critical for HIV genome replication and integration into host DNA. **Nef** (negative regulatory factor) is an accessory protein that enhances viral infectivity, modulates host cell signaling, and assists immune evasion[1][3][6]. **Env** is the viral envelope glycoprotein responsible for binding to and fusing with host cells. These proteins are all considered validated therapeutic targets for antiretroviral therapy[3][7]. However, grouping multiple protein products as a single therapeutic target is not standard: each is typically addressed individually in research and drug development, and their mechanisms of action, role in disease, and inhibitor classes partially overlap but are distinct in detail.

Other names
group-specific antigenpolymerasenegative regulatory factorenvelope glycoproteinHIV-1 structural proteinsHIV-1 enzymes
02

Mechanism of action

Inhibition of protease activity (prevents polyprotein cleavage, blocking maturation)\nInhibition of reverse transcriptase or integrase (blocking viral replication)\nInhibition of envelope-mediated fusion or entry\nCapsid assembly inhibition (preven ts proper virion formation)

03

Biological functions

Virus assembly and maturationViral genome packagingEnzymatic functions (reverse transcriptase, integrase, protease)Immune evasionHost cell entry and membrane fusionModulation of host cell signalingEnhancement of viral infectivity
04

Disease associations

Infection (HIV/AIDS)
05

Safety considerations

Drug resistance (mutation in viral genes encoding these proteins)Cytotoxicity associated with therapy (off-target effects of some inhibitors)Immune reconstitution syndrome upon therapy initiation
06

Interacting drugs

Antiretroviral drugs (e.g., protease inhibitors, reverse transcriptase inhibitors, integrase inhibitors, entry inhibitors)

2 more in the full profile.

07

Biomarkers

Viral RNA (for HIV-1 load monitoring)p24 antigen (Gag-derived; diagnostic/monitoring marker)Resistance mutation profiles in Pol

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 Gag, Pol, Nef, and Env proteins (HIV-1 Gag, Pol, Nef, and Env).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 Gag, Pol, Nef, and Env proteins (HIV-1 Gag, Pol, Nef, and Env).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call